Journal
Investigational new drugs
Publication Date
6-1-2022
Volume
40
Issue
3
First Page
596
Last Page
605
Document Type
Open Access Publication
DOI
10.1007/s10637-022-01216-8
Rights and Permissions
Waqar, S.N., Robinson, C., Olszanski, A.J. et al. Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors. Invest New Drugs 40, 596–605 (2022). https://doi.org/10.1007/s10637-022-01216-8 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Waqar, Saiama N; Robinson, Clifford; Olszanski, Anthony J; Spira, Alexander; Hackmaster, Melissa; Lucas, Luisa; Sponton, Laura; Jin, Hulin; Hering, Ursula; Cronier, Damien; Grinberg, Marianna; Seithel-Keuth, Annick; Diaz-Padilla, Ivan; and Berlin, Jordan, "Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors." Investigational new drugs. 40, 3. 596 - 605. (2022).
https://digitalcommons.wustl.edu/oa_4/4461
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
Author Correction
